It has been one heck of a fourth quarter so far for investors in small biotech stocksThe sector has seen some whipsaw action in the first six weeks of the quarterSmall biotech stocks briefly entered official bear market territory toward the end of October after they were pummeled during the monthThey have ridden the general bounce back in the over...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.